Cardiovascular risk in chronic obstructive pulmonary disease

Maclay, J. D., McAllister, D. A. and MacNee, W. (2007) Cardiovascular risk in chronic obstructive pulmonary disease. Respirology, 12(5), pp. 634-641. (doi: 10.1111/j.1440-1843.2007.01136.x) (PMID:17875049)

Full text not currently available from Enlighten.

Abstract

Cardiovascular disease (CVD) contributes significantly to morbidity and mortality in COPD. There is a high prevalence of traditional risk factors in this patient group including smoking, sedentary behaviour and low socio-economic class. However, large studies have shown that airflow limitation is an independent risk factor for CVD. Therefore there may be a 'COPD effect' that contributes to CVD in this condition, adding to the body of evidence that COPD has important systemic consequences, as well as being a lung disease. In this article, we review the evidence for CVD in COPD. Next, we examine systemic factors present in COPD, and link these to the pathogenesis of atherosclerosis, including inflammation, oxidative stress and hypoxia. Finally, we review those studies that have investigated therapeutic interventions in COPD that may modify cardiovascular risk.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McAllister, Professor David
Authors: Maclay, J. D., McAllister, D. A., and MacNee, W.
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Public Health
Journal Name:Respirology
Publisher:Wiley
ISSN:1323-7799
ISSN (Online):1440-1843
Published Online:14 September 2007

University Staff: Request a correction | Enlighten Editors: Update this record